**8. Conclusions**

Cardiac amyloidosis, previously believed to be a rare condition, is often underdiagnosed. Multisystemic presentations cause delays in diagnosis, which reduces the opportunity of treatment at initial stages. The advent of disease advanced multi-imaging modalities has improved identification and diagnosis of disease, with non-invasive diagnosis becoming cornerstone in treatment decision making process. Patient stratification is key for treatment decision and prognosis. Early diagnosis is key for prognosis, course of action, successful response to therapy, and a better treatment outcome.
